echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > What is the impact of the epidemic on the investment and financing of major health industries in 2020?

    What is the impact of the epidemic on the investment and financing of major health industries in 2020?

    • Last Update: 2020-02-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The outbreak of new coronavirus pneumonia since December 2019 has had a huge impact on various industries at home and abroad As a practitioner of the health industry, Haoyue capital, while actively contributing to the fight against the epidemic, also pays close attention to the impact of the epidemic on the development of the industry and the company and related investment and financing From January 31 to February 1, 2020, Haoyue Capital Research Institute investigated about 300 employees of well-known investment institutions in the form of anonymous questionnaires to understand their expectations about the impact of the current epidemic on the 2020 major health investment and financing The questions cover the judgment of the financing rhythm of the invested enterprise, the performance impact of the invested enterprise, research and roadshow methods, institutional fundraising and investment rhythm, and the impact of subdividing the track, etc The results are summarized and analyzed as follows: More than 40% of respondents suggested that the invested enterprises start financing as soon as possible, and 20% suggested that the invested enterprises suspend financing In the near future, some enterprises that are affected by the epidemic have completed financing and M & A for details, please refer to the latest weekly report of Haoyue capital The current epidemic has a great impact on transportation, more than 80% of the respondents accept off-site investigation, and more than 5% tend to work in the form of video conference More than 60% of the respondents think that the performance of the invested enterprise in the current year may be affected by the epidemic to some extent, and they suggest that the performance expectation of this year should be appropriately lowered This survey result is different from the judgment of the majority of people after the outbreak that the health care industry is good We believe that the reason for this survey result is that the large health industry covers a wide range, and the track directly benefiting from the epidemic, such as antiviral drugs, preventive vaccines, clinical infection testing, and macro genomic microbial testing, accounts for a small proportion of the whole At the same time, the epidemic is also an opportunity to re-examine the investment value of the sub circuit and avoid local overheating More than half of the respondents have the same pace of fundraising, and nearly 40% plan to speed up fundraising According to the survey results, the overall mentality of the surveyed investors is relatively stable We believe that the epidemic is expected to enable the government to further increase investment in medical care and support industrial innovation while carrying out medical insurance control and reducing unreasonable prices of drug consumables Nearly half of the respondents invested according to the original plan, nearly 40% slowed down their investment, and about 15% accelerated their investment For the enterprises in the portfolio, about 40% of the respondents plan to connect with FA and make better financial planning for them Similarly, about 40% of the respondents will continue to hold the invested projects 5 Impact on IVD precision medicine subdivision track The sudden outbreak has brought a major test to the response ability of the medical system in various regions, and also highlighted that the basic ability of the hospital still needs to be strengthened at present, especially in the fields of detection, logistics supply, equipment maintenance, etc., all kinds of third-party service companies have played an important role in the response to the epidemic On the other hand, according to the data during the new year, the indicators such as online daily life of smart medical companies such as telemedicine and medical e-commerce have also increased significantly In this epidemic, the habits of online business use cultivated by everyone will continue after the epidemic, and it is expected that a number of smart medical companies focusing on online business will usher in opportunities In addition, the epidemic is expected to strengthen the public awareness of risk prevention, and health insurance is expected to usher in a wave of consumption climax The novel coronavirus pneumonia there was no parallel in history The outbreak of the new coronavirus pneumonia caused a great concern to the health industry in the whole country It is an unprecedented health education for all The national population is expected to continue to increase health expenditure China's novel coronavirus pneumonia epidemic shows a good social responsibility, rapid innovation capability and positive role in the clinical line, and will also enhance investor confidence in the field of big health For investment institutions, through this epidemic situation, we can more directly see the subdivisions of China's medical services, devices, diagnosis and innovative drugs that need to be improved, so as to tap relevant innovative companies with potential, such as more accurate and rapid detection reagents, shortening the gap between the development of new drugs and vaccines and international leading enterprises, and further popularization of telemedicine, etc At the same time, the majority of respondents maintain the original holding plan for the invested enterprises and support accelerating the start of a new round of financing.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.